Naloxone Inj
General Drug Information and Indications
Opioid antagonist for reversal of opioid-induced respiratory depression and toxicity in horses and small animals.
Opioid receptor antagonist (naloxone HCl). Mechanism: competitive antagonist at mu, kappa, and delta opioid receptors → rapidly reverses opioid-induced CNS and respiratory depression. Pure antagonist (no agonist activity). Short half-life (45–90 min); may need redosing. IV onset within 2 min. Does not reverse benzodiazepine or other CNS depressant effects.
Key information
Opioid reversal agent. IV preferred for fastest action; IM or SQ if IV unavailable. Duration shorter than most opioids — repeat dosing may be needed. Precipitates acute withdrawal — use cautiously in opioid-dependent animals. Refrigerate.
How to Give this Medication
IV: administer rapidly IV for opioid reversal. IM or SQ: if no IV access. Sublingual or intratracheal: if no peripheral access. May repeat every 2–3 min as needed. Monitor for re-narcotization (short half-life) — may require CRI or repeat boluses. Store at room temperature; protect from light.
If a dose is missed
This medication is administered by a veterinarian or veterinary staff in a clinical setting. Missed doses are managed by your veterinary team — contact your veterinarian to reschedule.
Side Effects
Reversal of opioid analgesia (abrupt pain return — manage post-reversal pain appropriately). Opioid withdrawal syndrome: agitation, tachycardia, vomiting, sweating. Pulmonary edema (rare, with rapid reversal of opioid depression in humans). Short half-life — renarcotization possible (re-dose if needed).
Precautions
For animals
Short half-life (45–90 min) — re-narcotization possible after reversal of long-acting opioids; repeat dosing or CRI may be required. Reversal of analgesia: pain returns abruptly — manage pain appropriately post-reversal. Does not reverse non-opioid CNS depressants.
For people handling this medication
Wash hands thoroughly with soap and water after handling. Avoid contact with eyes; if contact occurs, flush with water for 15 minutes and seek medical attention. Keep out of reach of children. If accidental ingestion occurs, contact Poison Control (1-800-222-1222). Opioid antagonist — generally safe to handle. If accidentally injected (in opioid-dependent persons), will precipitate withdrawal. Keep out of reach of children.
Overdose
Overdose is managed by veterinary staff in a clinical setting. If an error occurred during in-hospital treatment, the attending veterinary team will manage the response.
Naloxone Inj dosage forms
| Product | Strength | Form | Size | Type |
|---|---|---|---|---|
| NALOXONE INJ 0.4MG/ML | 0.4MG/ML | Injectable | — | Commercial |
| NALOXONE INJ 0.4MG/ML | 0.4MG/ML | Injectable | — | Commercial |
| NALOXONE INJ 0.4MG/ML | 0.4MG/ML | Injectable | — | Commercial |
| NALOXONE INJ 4MG/10ML | 4 MG | Injectable | 1 | Commercial |
Sources
This information is provided for educational purposes and is not a substitute for advice from your veterinarian. Source: Merck Veterinary Manual (merckvetmanual.com); Plumb's Veterinary Drug Handbook (Plumb, D.C., app.plumbs.com)